Synairgen Aims To Disprove Doubts About Interferon Therapy In COVID-19

Nebulized Formulation ‘Is Key’

 
• By Andrew McConaghie
  
Hospital blur
Synairgen will shortly launch a Phase III trial of its nebulized interferon beta treatment in hospitalized patients.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip